Patents by Inventor Doug F. KLING

Doug F. KLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENCHOLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS
    Publication number: 20210393526
    Abstract: The present application is directed to a cochleate composition including one or more cochleates and at least two anti-fungal compounds selected from amphotericin B, 5-flucytosine, fluconazole, ketoconazole, ravuconazole, albaconazole, itraconazole, oposaconazole, isavuconazole and/or voriconazole. Methods of using the antifungal cochleate formulations are also disclosed.
    Type: Application
    Filed: August 31, 2021
    Publication date: December 23, 2021
    Inventors: Raphael J. Mannino, Ruying Lu, Doug F. Kling
  • Encholeated antifungal compounds for central nervous system delivery and treatment of infections
    Patent number: 11123295
    Abstract: The present application is directed to a cochleate composition including one or more cochleates and at least two antifungal compounds selected from amphotericin B, 5-flucytosine, fluconazole, ketoconazole, ravuconazole, albaconazole, itraconazole, posaconazole, isavuconazole and/or voriconazole. Methods of using the antifungal cochleate formulations are also disclosed.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: September 21, 2021
    Assignee: MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
    Inventors: Raphael J. Mannino, Ruying Lu, Doug F. Kling
  • ENCHOLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS
    Publication number: 20200121601
    Abstract: The present application is directed to a cochleate composition including one or more cochleates and at least two antifungal compounds selected from amphotericin B, 5-flucytosine, fluconazole, ketoconazole, ravuconazole, albaconazole, itraconazole, posaconazole, isavuconazole and/or voriconazole. Methods of using the antifungal cochleate formulations are also disclosed.
    Type: Application
    Filed: July 12, 2017
    Publication date: April 23, 2020
    Applicant: Matinas BioPharma Nanotechnologies, Inc.
    Inventors: Raphael J. MANNINO, Ruying LU, Doug F. KLING